Neonatal Screening: Identification of Children with 11β-Hydroxylase Deficiency by Second-Tier Testing
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: 21-Hydroxylase deficiency (21-OHD) is the target disease of newborn screening for congenital adrenal hyperplasia (CAH). We describe the additional detection of patients suffering from 11β-hydroxylase deficiency (11-OHD) by second-tier testing. METHOD: Over a period of 5 years, screening for CAH was done in a total of 986,098 newborns by time-resolved immunoassay (DELFIA®) for 17α-hydroxyprogesterone (17-OHP). Positive samples were subsequently analyzed in an LC-MS/MS second-tier test including 17-OHP, cortisol, 11-deoxycortisol, 4-androstenedione and 21-deoxycortisol. RESULTS: In addition to 78 cases of 21-OHD, 5 patients with 11-OHD were identified. Diagnostic parameters were a markedly elevated concentration of 11-deoxycortisol in the presence of a low level of cortisol. Androstenedione was also increased. In contrast to 21-OHD, concentrations of 21-deoxycortisol were normal. CONCLUSION: Steroid profiling in newborn blood samples showing positive results in immunoassays for 17-OHP allows for differentiating 21-OHD from 11-OHD. This procedure may not detect all cases of 11-OHD in the newborn population because there may be samples of affected newborns with negative results for 17-OHP in the immunoassay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Product ratios are particularly useful in distinguishing enzymatic defects (164, 165).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [165]
In the citing paper
“Second-tier screening with LC-MS/MS can efficiently measure a panel of steroids and permit diagnosis of other forms of CAH, as has been shown for 11b-hydroxylase deficiency (164, 165).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [165]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[Principles and practice of mass screening for disease].
Wilson, J. M., & Jungner, Y. G. (1968) · PubMed · Cited by 1,036
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Steroid 11β- hydroxylase deficiency congenital adrenal hyperplasia
Nimkarn, S., & New, M. I. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.01.002 · Cited by 237
Janzen, N., Peter, M., Sander, S., Steuerwald, U., Terhardt, M., Holtkamp, U., & Sander, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2890 · Cited by 211
Self-citationPLASMA AND URINARY CORTICOSTEROIDS IN THE HYPERTENSIVE FORM OF CONGENITAL ADRENAL HYPERPLASIA
Eberlein, W. R., & Bongiovanni, A. M. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65119-1 · Cited by 172
Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS
Honda, A., Yamashita, K., Miyazaki, H., Shirai, M., Ikegami, T., Xu, G., Numazawa, M., Hara, T., & Matsuzaki, Y. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d800017-jlr200 · Cited by 164
Janzen, N., Sander, S., Terhardt, M., Peter, M., & Sander, J. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.11.006 · Cited by 119
Self-citationSteroid measurement with LC–MS/MS in pediatric endocrinology
Rauh, M. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.007 · Cited by 113
Schwarz, E., Liu, A., Randall, H., Haslip, C., Keune, F., Murray, M., Longo, N., & Pasquali, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181aa3777 · Cited by 97
Janzen, N., Sander, S., Terhardt, M., Steuerwald, U., Peter, M., Das, A. M., & Sander, J. (2011) · Steroids · doi:10.1016/j.steroids.2011.07.013 · Cited by 66
Self-citation
Research works printed but not linked: 10
- Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW: Corrected 17 ␣ -hydroxyprogester- one values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants. Ann Clin Lab Sci 2008; 38: 235-240.
- Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J: Newborn screening for congenital adrenal hyperpla- sia: additional steroid profile using liquid chromatography-tandem mass spectrome- try. J Clin Endocrinol Metab 2007; 92: 2581- 2589.
- Janzen N, Sander S, Terhardt M, Peter M, Sander J: Fast and direct quantification of adrenal steroids by tandem mass spectrom- etry in serum and dried blood spots. J Chro- matogr B Analyt Technol Biomed Life Sci 2008; 861: 117-122.
- Krone N, Riepe FG, Gotze D, Korsch E, Ris- ter M, Commentz J, Partsch CJ, Grotzinger J, Peter M, Sippell WG: Congenital adrenal hy- perplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair dele- tion in the CYP11B1 gene. J Clin Endocrinol Metab 2005; 90: 3724-3730.
- Schwarz E, Liu A, Randall H, Haslip C, Keune F, Murray M, Longo N, Pasquali M: Use of steroid profiling by UPLC-MS/MS as a second-tier test in newborn screening for congenital adrenal hyperplasia: the Utah ex- perience. Pediatr Res 2009; 66: 230-235.
- De Jesus VR, Simms DA, Schiffer J, Kennedy M, Mei JV, Hannon WH: Pilot proficiency testing study for second tier congenital ad- renal hyperplasia newborn screening. Clin Chim Acta 2010; 411: 1684-1687.
- Rauh M: Steroid measurement with LC-MS/ MS in pediatric endocrinology. Mol Cell En- docrinol 2009; 301: 272-281.
- Honda A, Yamashita K, Miyazaki H, Shirai M, Ikegami T, Xu G, Numazawa M, Hara T, Matsuzaki Y: Highly sensitive analysis of ste- rol profiles in human serum by LC-ESI-MS/ MS. J Lipid Res 2008; 49: 2063-2073.
- Janzen N, Sander S, Terhardt M, Steuerwald U, Peter M, Das AM, Sander J: Rapid steroid hormone quantification for congenital adre- nal hyperplasia in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry. Steroids 2011; 76: 1437-1442.
- Nimkarn S, New MI: Steroid 11  -hydroxy- lase deficiency congenital adrenal hyperpla- sia. Trends Endocrinol Metab 2008; 19: 96- 99.
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Congenital adrenal hyperplasia: time to replace 17OHP with 21-deoxycortisol
Miller, W. L. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501396 · Cited by 93
Abdel‐Khalik, J., Björklund, E., & Hansen, M. A. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.03.013 · Cited by 82
Eissa, S., Siddiqua, A., Chinnappan, R., & Zourob, M. M. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00294 · Cited by 55
Determination of a steroid profile in heel prick blood using LC-MS/MS
Boelen, A., Ruiter, A. F., Claahsen-van der Grinten, H. L., Endert, E., & Ackermans, M. T. (2016) · Bioanalysis · doi:10.4155/bio.16.6 · Cited by 49
Mass spectrometry theory and application to adrenal diseases
Wooding, K. M., & Auchus, R. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.026 · Cited by 37
Gaudl, A., Kratzsch, J., & Ceglarek, U. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105389 · Cited by 37
Baş, F., Toksoy, G., Ergun-Longmire, B., Uyguner, Z. O., Abalı, Z. Y., Poyrazoğlu, Ş., Karaman, V., Avcı, Ş., Altunoğlu, U., Bundak, R., et al. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.04.001 · Cited by 36
Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
Tsuji‐Hosokawa, A., & Kashimada, K. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7030036 · Cited by 34
Biphenyl based stationary phases for improved selectivity in complex steroid assays
Lindner, J. M., Vogeser, M., & Grimm, S. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.04.020 · Cited by 34
Stroek, K., Ruiter, A. F. C., van der Linde, A., Ackermans, M. T., Bouva, M. J., Engel, H., Jakobs, B. S., Kemper, E. A., van den Akker, E. L. T., van Albada, M. E., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab464 · Cited by 34
Congenital Adrenal Hyperplasia: Issues in Diagnosis and Treatment in Children
Sharma, R., & Seth, A. (2013) · The Indian Journal of Pediatrics · doi:10.1007/s12098-013-1280-8 · Cited by 31
Choukair, D., Hauck, F. H., Bettendorf, M., Krude, H., Klein, C., Bäumer, T., Berner, R., Lee‐Kirsch, M. A., Grasemann, C., Burgard, P. J., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02092-w · Cited by 25
Breil, T., Yakovenko, V., Inta, I. M., Choukair, D., Klose, D., Mittnacht, J., Schulze, E., Alrajab, A., Grulich‐Henn, J., & Bettendorf, M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0298 · Cited by 22
High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia
Levy‐Shraga, Y., & Pinhas‐Hamiel, O. (2016) · BMJ Case Reports · doi:10.1136/bcr-2015-213939 · Cited by 20
Karlekar, M. P., Sarathi, V., Lila, A. R., Rai, K., Arya, S., Bhandare, V. V., Atluri, S., Patil, V. A., Ramteke‐Jadhav, S., Shah, N. S., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14376 · Cited by 17
Watanabe, K., Tsuji‐Hosokawa, A., Hashimoto, A., Konishi, K., Ishige, N., Yajima, H., Sutani, A., Nakatani, H., Gau, M., Takasawa, K., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac521 · Cited by 16
3?-hydroxysteroid dehydrogenase type II deficiency on newborn screening test
de Araújo, V. G. B., Oliveira, R., Gameleira, K. P. D., Cruz, C. B., & Lofrano‐Porto, A. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003098 · Cited by 15
Li, Z., Liang, Y., Du, C., Xiao, Y., Hou, L., Wu, W., Ying, Y., & Luo, X. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00901-8 · Cited by 12
Long, Q., Zhang, T., Yan, Y., Zhao, H., Zhou, W., Zeng, J., Li, S., Zhang, J., Zeng, Q., Zhao, B., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0410 · Cited by 9
Rare forms of congenital adrenal hyperplasia: pathogenesis, clinical, treatment and management
Cavarzere, P., lupieri, V., battiston, R., Mancioppi, V., & Maffeis, C. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02750-x · Cited by 5
Rhouati, A., Mohamed, R. R., Chandel, M., Eisawi, K., Naguib, M., Jastrzębska, A., & Zourob, M. M. (2025) · Materials Advances · doi:10.1039/d4ma01181c · Cited by 5
The presentation of congenital adrenal hyperplasia in an unscreened population
Conlon, T. A., Hawkes, C. P., Brady, J. J., & Murphy, N. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0123 · Cited by 4
Identification and functional characterization of compound heterozygous CYP11B1 gene mutations
Liu, H., Liu, F., Wei, Z., Liu, P., Liu, Q., Chen, L., & Hou, X. (2024) · Endocrine · doi:10.1007/s12020-023-03614-1 · Cited by 3
High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians
Makretskaya, N., Kalinchenko, N. Y., Tebieva, I. S., Ionova, S. A., Zinchenko, R. A., Владимирович, М. А., & Tiulpakov, A. N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1146768 · Cited by 3
Hyperkalemic Renal Tubular Acidosis (RTA Type IV)
Lagunas-Muñoz, J., & Muñoz, R. (2022) · Springer eBooks · doi:10.1007/978-3-030-91940-5_10 · Cited by 2
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00005-x · Cited by 1
Clinical practice guidelines "Congenital adrenal hyperplasia in children" with comments
Чугунов, І., Kopylova, I., Kolodkina, A. A., Kalinchenko, N. Y., Vorontsova, M. V., Bezlepkina, O. B., Peterkova, V. A., & Mokrysheva, N. G. (2026) · Problems of Endocrinology · doi:10.14341/probl13767 · Cited by 1
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00004-8
Adrenal Multidisipliner Güncel Yaklaşım
Özen, F. Z., Özer, M., Özsoy, Ç., Binnetoğlu, E., Alparslan, A. Ş., Budak, E. S., Kök, E. V., Çetinkaya, G. S., Durmuş, M. E., Köker, G., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2992
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00012-7
A Two-Step LC-MS/MS method to differentiate 21OHD and PORD in Screen-Positive newborns
Nakatani, H., Watanabe, K., Tsuji‐Hosokawa, A., Sutani, A., Saito, Y., Kirino, S., Yamano, H., Orimoto, R., Gau, M., Yogi, A., et al. (2026) · Endocrine · doi:10.1007/s12020-026-04573-z
Predictive Value of Steroidal Hormones to Type 2 Diabetes and Metabolic Syndrome
Bunch, D. R. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Li, Z., Liang, Y., Du, C., Yu, X., Hou, L., Wu, W., Ying, Y., & Luo, X. (2021) · Figshare · doi:10.6084/m9.figshare.17083928
Li, Z., Liang, Y., Du, C., Yu, X., Hou, L., Wu, W., Ying, Y., & Luo, X. (2021) · Figshare · doi:10.6084/m9.figshare.17083925
Li, Z., Liang, Y., Du, C., Yu, X., Hou, L., Wu, W., Ying, Y., & Luo, X. (2021) · Figshare · doi:10.6084/m9.figshare.17083931
Tuli, G., Munarin, J., Pavanello, E., & SANCTIS, L. D. (2026) · Endocrine · doi:10.1007/s12020-026-04759-5
Novel approaches to corticosteroid profiling by stable isotope dilution tandem mass spectrometry
Lindner, J. M. (2018) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.23333
Metadata
- Authors
- Janzen, N., Riepe, F. G., Peter, M., Sander, S., Steuerwald, U., Korsch, E., Krull, F., Müller, H. L., Heger, S., Brack, C., & Sander, J.
- Affiliations
- University Hospitals of the Ruhr-University of Bochum (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Kliniken der Stadt Köln (DE)
- Kinderkrankenhaus auf der Bult (DE)
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 77
- Issue
- 3
- Pages
- 195-199
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W1972295191
- Cited by
- 37
- References
- 12
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 3 · 2014: 1 · 2013: 3
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- 11beta-hydroxylase deficiency, congenital adrenal hyperplasia, 21-hydroxylase deficiency, newborn screening, second-tier testing, 17-hydroxyprogesterone, 11-deoxycortisol, androstenedione, cortisol, steroid profiling, LC-MS/MS
- MeSH terms
- Adrenal Hyperplasia, Congenital, Androstenedione, Cortodoxone, False Positive Reactions, Female, Humans, Hydrocortisone, Infant, Infant, Newborn, Male, Steroid 11-beta-Hydroxylase, Neonatal Screening, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.